HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,267,109 | +4.5% | 14,145 | -0.7% | 0.23% | +9.5% |
| Q2 2023 | $1,212,564 | +2.3% | 14,242 | -0.6% | 0.21% | +1.0% |
| Q1 2023 | $1,185,559 | +6.8% | 14,327 | +1.5% | 0.21% | +8.9% |
| Q4 2022 | $1,110,223 | +6.8% | 14,116 | +0.5% | 0.19% | -2.0% |
| Q3 2022 | $1,040,000 | -6.0% | 14,051 | -17.2% | 0.20% | +2.1% |
| Q2 2022 | $1,106,000 | -6.7% | 16,965 | -4.7% | 0.19% | +46.6% |
| Q2 2021 | $1,186,000 | +33.0% | 17,804 | +78.7% | 0.13% | -9.0% |
| Q2 2020 | $892,000 | +26.5% | 9,964 | -36.6% | 0.14% | +45.5% |
| Q3 2017 | $705,000 | +60.2% | 15,715 | +15.4% | 0.10% | +13.8% |
| Q3 2015 | $440,000 | – | 13,615 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |